ViaDerma Announces Posting of Annual Report and Ongoing Evaluation of Public Status in Response to Market Changes
LOS ANGELES, July 16, 2025 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Expert Market: VDRM), a specialty pharmaceutical company, announced today that its 2024 Annual Report  has been posted to the company’s...
ViaDerma Announces the Implementation of Internal Quality Control Measures for its New Vitastem Products
The Company’s improved, new Vitastem products have recently begun large scale production...
ViaDerma's 2021 Annual Report Shows Strong Revenue Growth Over the Previous Year
Revenues increased by over 4000% in 2021, while liabilities decreased by more than 25%...